Combination therapies for previously untreated CLL

被引：1
|
作者：
Shanafelt, Tait D. [1 ]
Kay, Neil E. [1 ]
机构：
[1] Mayo Clin, Coll Med, Rochester, MN 55905 USA
来源：
LANCET | 2007年 / 370卷 / 9583期
关键词：
D O I：
10.1016/S0140-6736(07)61100-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：197 / 198
页数：2
相关论文
共 50 条
  • [41] Prospective Randomized Phase 2 Study of Acalabrutinib plus Obinutuzumab or Venetoclax in Previously Untreated CLL
    Kittai, Adam S.
    Huang, Ying
    Bhat, Seema A.
    Grever, Michael R.
    Suresh, Swetha
    Lozanski, Gerard
    Moran, Mollie
    Nussbaum, Megan
    Woyach, Jennifer A.
    Rogers, Kerry A.
    BLOOD, 2024, 144
  • [42] Alemtuzumab and Rituximab Combination Therapy for Patients with Untreated CLL - a Phase II Trial
    Frankfurt, Olga
    Hamilton, Elizabeth
    Duffey, Sara
    Acharya, Simbi
    Raji, Adekunle
    Ma, Shuo
    Peterson, Loann
    Goolsby, Charles
    Rosen, Steven T.
    BLOOD, 2008, 112 (11) : 730 - 730
  • [43] CAMPATH-1H therapy of patients with previously untreated chronic lymphocytic leukemia (CLL).
    Lundin, J
    Björkholm, M
    Celsing, F
    Hale, G
    Hjalmar, V
    Kimby, E
    Tullgren, O
    Waldman, H
    Mellstedt, H
    Österborg, A
    ANNALS OF ONCOLOGY, 2000, 11 : 96 - 96
  • [44] CAMPATH-1H therapy of patients with previously untreated chronic lymphocytic leukemia (CLL).
    Mellstedt, H
    Österborg, A
    Lundin, J
    Björkholm, M
    Celsing, F
    Hagberg, H
    Hast, R
    Hjalmar, V
    Kimby, E
    Luthman, M
    Tullgren, O
    Werner, B
    BLOOD, 1998, 92 (10) : 490A - 490A
  • [45] 2-CHLORODEOXYADENOSINE (CDA) FOR PATIENTS WITH PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL)
    DELANNOY, A
    MARTIAT, P
    GALA, JL
    DENEYS, V
    FERRANT, A
    BOSLY, A
    SCHEIFF, JM
    MICHAUX, JL
    LEUKEMIA, 1995, 9 (07) : 1130 - 1135
  • [46] Results of the randomized phase IIB ADMIRE trial of FCR with or without mitoxantrone in previously untreated CLL
    T Munir
    D R Howard
    L McParland
    C Pocock
    A C Rawstron
    A Hockaday
    A Varghese
    M Hamblin
    A Bloor
    A Pettitt
    C Fegan
    J Blundell
    J G Gribben
    D Phillips
    P Hillmen
    Leukemia, 2017, 31 : 2085 - 2093
  • [47] Oral fludarabine and cyclophosphamide in previously untreated chronic lymphocytic leukemia (CLL): Preliminary data.
    Cazin, B
    Binet, JL
    Divine, M
    Lepretre, S
    Lederlin, P
    Travade, P
    Lemaire, G
    Guibon, O
    BLOOD, 2000, 96 (11) : 515A - 515A
  • [48] EVALUATION OF 2 COMBINATION CHEMOTHERAPIES IN PREVIOUSLY UNTREATED NON HODGKINS LYMPHOMA
    SOMOZA, N
    PAVLOVSKY, S
    SUAREZ, A
    MORGENFELD, M
    BESUSCHIO, SC
    BEZARES, R
    MICHEO, EQ
    LEIN, JM
    DEMARIA, H
    MEDICINA-BUENOS AIRES, 1981, 41 : 35 - 43
  • [49] EVALUATION OF 2 COMBINATION CHEMOTHERAPIES IN PREVIOUSLY UNTREATED NON HODGKINS LYMPHOMA
    PAVLOVSKY, S
    SOMOZA, N
    SUAREZ, A
    MORGENFELD, M
    BEZARES, R
    MICHEO, EQ
    LEIN, JM
    DEMARIA, H
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 117 - 117
  • [50] Bortezomib in combination with thalidomide-dexamethasone for previously untreated multiple myeloma
    Wang, M.
    Giralt, S.
    Delasalle, K.
    Handy, B.
    Alexanian, R.
    HEMATOLOGY, 2007, 12 (03) : 235 - 239
12345